Role of HSF1 in cell division, tumorigenesis and therapy: a literature review
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14310%2F25%3A00141604" target="_blank" >RIV/00216224:14310/25:00141604 - isvavai.cz</a>
Result on the web
<a href="https://celldiv.biomedcentral.com/articles/10.1186/s13008-025-00153-1" target="_blank" >https://celldiv.biomedcentral.com/articles/10.1186/s13008-025-00153-1</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1186/s13008-025-00153-1" target="_blank" >10.1186/s13008-025-00153-1</a>
Alternative languages
Result language
angličtina
Original language name
Role of HSF1 in cell division, tumorigenesis and therapy: a literature review
Original language description
Heat shock factor 1 (HSF1) is the master orchestrator of the heat shock response (HSR), a critical process for maintaining cellular health and protein homeostasis. These effects are achieved through rapid expression of molecular chaperones, the heat shock proteins (HSPs), which ensure correct protein folding, repair, degradation and stabilization of multiprotein complexes. In addition to its role in the HSR, HSF1 influences the cell cycle, including processes such as S phase progression and regulation of the p53 pathway, highlighting its importance in cellular protein synthesis and division. While HSF1 activity offers neuroprotective benefits in neurodegenerative diseases, its proteome-stabilizing function may also reinforce tumorigenic transformation. HSF1 overexpression in many types of cancer reportedly enhances cell growth enables survival, alters metabolism, weakens immune response and promotes angiogenesis or epithelial-mesenchymal transition (EMT) as these cells enter a form of “HSF1 addiction”. Furthermore, the client proteins of HSF1-regulated chaperones, particularly Hsp90, include numerous key players in classical tumorigenic pathways. HSF1 thus presents a promising therapeutic target for cancer treatment, potentially in combination with HSP inhibitors to alleviate typical initiation of HSR upon their use.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
10601 - Cell biology
Result continuities
Project
—
Continuities
S - Specificky vyzkum na vysokych skolach
Others
Publication year
2025
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Cell Division
ISSN
1747-1028
e-ISSN
1747-1028
Volume of the periodical
20
Issue of the periodical within the volume
1
Country of publishing house
GB - UNITED KINGDOM
Number of pages
15
Pages from-to
1-15
UT code for WoS article
001476238500001
EID of the result in the Scopus database
2-s2.0-105003702031